HEADER IMMUNE SYSTEM 18-FEB-18 6FS2 TITLE MCL1 IN COMPLEX WITH INDOLE ACID LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL- COMPND 3 1; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: BCL-2-LIKE PROTEIN 3,BCL2-L-3,BCL-2-RELATED PROTEIN COMPND 6 EAT/MCL1,MCL1/EAT; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MCL1, BCL2L3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MCL1, INDOLE ACID, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR D.HARGREAVES REVDAT 2 02-OCT-19 6FS2 1 COMPND SOURCE REMARK DBREF REVDAT 2 2 1 SEQRES CRYST1 ATOM REVDAT 1 26-DEC-18 6FS2 0 JRNL AUTH A.E.TRON,M.A.BELMONTE,A.ADAM,B.M.AQUILA,L.H.BOISE, JRNL AUTH 2 E.CHIARPARIN,J.CIDADO,K.J.EMBREY,E.GANGL,F.D.GIBBONS, JRNL AUTH 3 G.P.GREGORY,D.HARGREAVES,J.A.HENDRICKS,J.W.JOHANNES, JRNL AUTH 4 R.W.JOHNSTONE,S.L.KAZMIRSKI,J.G.KETTLE,M.L.LAMB,S.M.MATULIS, JRNL AUTH 5 A.K.NOOKA,M.J.PACKER,B.PENG,P.B.RAWLINS,D.W.ROBBINS, JRNL AUTH 6 A.G.SCHULLER,N.SU,W.YANG,Q.YE,X.ZHENG,J.P.SECRIST,E.A.CLARK, JRNL AUTH 7 D.M.WILSON,S.E.FAWELL,A.W.HIRD JRNL TITL DISCOVERY OF MCL-1-SPECIFIC INHIBITOR AZD5991 AND JRNL TITL 2 PRECLINICAL ACTIVITY IN MULTIPLE MYELOMA AND ACUTE MYELOID JRNL TITL 3 LEUKEMIA. JRNL REF NAT COMMUN V. 9 5341 2018 JRNL REFN ESSN 2041-1723 JRNL PMID 30559424 JRNL DOI 10.1038/S41467-018-07551-W REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 10720 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.830 REMARK 3 FREE R VALUE TEST SET COUNT : 947 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.030 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.85 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.88 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3044 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2310 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2777 REMARK 3 BIN R VALUE (WORKING SET) : 0.2260 REMARK 3 BIN FREE R VALUE : 0.2730 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.77 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 267 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2433 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 132 REMARK 3 SOLVENT ATOMS : 40 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.55 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.42140 REMARK 3 B22 (A**2) : 1.79890 REMARK 3 B33 (A**2) : -4.22040 REMARK 3 B12 (A**2) : 3.00550 REMARK 3 B13 (A**2) : 2.07750 REMARK 3 B23 (A**2) : 2.11980 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.310 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.810 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.307 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.700 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.322 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.873 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2626 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3541 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 957 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 67 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 373 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2626 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 314 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3117 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.69 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.09 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FS2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1200008847. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-FEB-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10721 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 45.220 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: UNKNOWN, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 196 REMARK 465 LYS A 197 REMARK 465 THR B 196 REMARK 465 LYS B 197 REMARK 465 GLU B 325 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 176 CD NE CZ NH1 NH2 REMARK 480 ARG A 187 CZ NH1 NH2 REMARK 480 LEU A 199 CG CD1 CD2 REMARK 480 GLU A 211 CD OE1 OE2 REMARK 480 GLU A 240 CG CD OE1 OE2 REMARK 480 LYS A 244 CG CD CE NZ REMARK 480 ASP A 256 CG OD1 OD2 REMARK 480 VAL A 258 CG1 CG2 REMARK 480 GLU A 288 CG CD OE1 OE2 REMARK 480 ARG A 300 NE CZ NH1 NH2 REMARK 480 LYS A 308 CG CD CE NZ REMARK 480 ARG A 310 CG CD NE CZ NH1 NH2 REMARK 480 GLU A 322 CG CD OE1 OE2 REMARK 480 ASP A 323 CG OD1 OD2 REMARK 480 ARG B 176 CD NE CZ NH1 NH2 REMARK 480 GLU B 180 CG CD OE1 OE2 REMARK 480 SER B 193 OG REMARK 480 ARG B 207 CG CD NE CZ NH1 NH2 REMARK 480 ARG B 208 CD NE CZ NH1 NH2 REMARK 480 GLU B 211 CG CD OE1 OE2 REMARK 480 GLU B 240 CG CD OE1 OE2 REMARK 480 LYS B 244 CG CD CE NZ REMARK 480 VAL B 258 CG1 CG2 REMARK 480 GLU B 288 OE1 OE2 REMARK 480 GLU B 292 OE1 OE2 REMARK 480 LYS B 308 CD CE NZ REMARK 480 GLU B 322 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 175 -60.41 154.22 REMARK 500 LEU A 199 -72.73 -87.76 REMARK 500 ASP A 323 51.31 -105.25 REMARK 500 LEU B 199 -76.05 -82.35 REMARK 500 ASP B 236 63.86 33.93 REMARK 500 SER B 245 -8.00 -59.59 REMARK 500 GLU B 322 54.49 -152.88 REMARK 500 ASP B 323 40.55 -106.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E4K A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E4K A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E4K B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E4K B 402 DBREF 6FS2 A 174 325 UNP Q07820 MCL1_HUMAN 174 325 DBREF 6FS2 B 174 325 UNP Q07820 MCL1_HUMAN 174 325 SEQADV 6FS2 ASP A 172 UNP Q07820 EXPRESSION TAG SEQADV 6FS2 ASP A 173 UNP Q07820 EXPRESSION TAG SEQADV 6FS2 SER A 193 UNP Q07820 ALA 193 CONFLICT SEQADV 6FS2 LEU A 199 UNP Q07820 MET 199 CONFLICT SEQADV 6FS2 GLU A 201 UNP Q07820 ARG 201 CONFLICT SEQADV 6FS2 ALA A 202 UNP Q07820 SER 202 CONFLICT SEQADV 6FS2 ALA A 205 UNP Q07820 THR 205 CONFLICT SEQADV 6FS2 GLY A 206 UNP Q07820 SER 206 CONFLICT SEQADV 6FS2 ARG A 208 UNP Q07820 LYS 208 CONFLICT SEQADV 6FS2 ASP B 172 UNP Q07820 EXPRESSION TAG SEQADV 6FS2 ASP B 173 UNP Q07820 EXPRESSION TAG SEQADV 6FS2 SER B 193 UNP Q07820 ALA 193 CONFLICT SEQADV 6FS2 LEU B 199 UNP Q07820 MET 199 CONFLICT SEQADV 6FS2 GLU B 201 UNP Q07820 ARG 201 CONFLICT SEQADV 6FS2 ALA B 202 UNP Q07820 SER 202 CONFLICT SEQADV 6FS2 ALA B 205 UNP Q07820 THR 205 CONFLICT SEQADV 6FS2 GLY B 206 UNP Q07820 SER 206 CONFLICT SEQADV 6FS2 ARG B 208 UNP Q07820 LYS 208 CONFLICT SEQRES 1 A 154 ASP ASP LEU TYR ARG GLN SER LEU GLU ILE ILE SER ARG SEQRES 2 A 154 TYR LEU ARG GLU GLN ALA THR GLY SER LYS ASP THR LYS SEQRES 3 A 154 PRO LEU GLY GLU ALA GLY ALA ALA GLY ARG ARG ALA LEU SEQRES 4 A 154 GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN ARG ASN SEQRES 5 A 154 HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS LEU ASP SEQRES 6 A 154 ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER ARG VAL SEQRES 7 A 154 MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN TRP GLY SEQRES 8 A 154 ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE VAL ALA SEQRES 9 A 154 LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS ILE GLU SEQRES 10 A 154 PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL ARG THR SEQRES 11 A 154 LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP ASP GLY SEQRES 12 A 154 PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU SEQRES 1 B 154 ASP ASP LEU TYR ARG GLN SER LEU GLU ILE ILE SER ARG SEQRES 2 B 154 TYR LEU ARG GLU GLN ALA THR GLY SER LYS ASP THR LYS SEQRES 3 B 154 PRO LEU GLY GLU ALA GLY ALA ALA GLY ARG ARG ALA LEU SEQRES 4 B 154 GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN ARG ASN SEQRES 5 B 154 HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS LEU ASP SEQRES 6 B 154 ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER ARG VAL SEQRES 7 B 154 MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN TRP GLY SEQRES 8 B 154 ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE VAL ALA SEQRES 9 B 154 LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS ILE GLU SEQRES 10 B 154 PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL ARG THR SEQRES 11 B 154 LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP ASP GLY SEQRES 12 B 154 PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU HET E4K A 401 33 HET E4K A 402 33 HET E4K B 401 33 HET E4K B 402 33 HETNAM E4K 7-(2-METHYLPHENYL)-3-[3-(5,6,7,8-TETRAHYDRONAPHTHALEN- HETNAM 2 E4K 1-YLOXY)PROPYL]-1~{H}-INDOLE-2-CARBOXYLIC ACID FORMUL 3 E4K 4(C29 H29 N O3) FORMUL 7 HOH *40(H2 O) HELIX 1 AA1 ASP A 172 GLY A 192 1 21 HELIX 2 AA2 ALA A 204 HIS A 224 1 21 HELIX 3 AA3 HIS A 224 ASP A 236 1 13 HELIX 4 AA4 ASN A 239 SER A 245 1 7 HELIX 5 AA5 SER A 245 SER A 255 1 11 HELIX 6 AA6 ASN A 260 ILE A 281 1 22 HELIX 7 AA7 GLN A 283 SER A 285 5 3 HELIX 8 AA8 CYS A 286 GLN A 309 1 24 HELIX 9 AA9 GLY A 311 PHE A 319 1 9 HELIX 10 AB1 ASP B 173 GLY B 192 1 20 HELIX 11 AB2 ALA B 204 HIS B 224 1 21 HELIX 12 AB3 HIS B 224 ASP B 236 1 13 HELIX 13 AB4 ASN B 239 SER B 245 1 7 HELIX 14 AB5 LEU B 246 SER B 255 1 10 HELIX 15 AB6 ASN B 260 ILE B 281 1 22 HELIX 16 AB7 GLN B 283 SER B 285 5 3 HELIX 17 AB8 CYS B 286 GLN B 309 1 24 HELIX 18 AB9 GLY B 311 PHE B 319 1 9 SITE 1 AC1 10 MET A 231 VAL A 249 HIS A 252 VAL A 253 SITE 2 AC1 10 E4K A 402 ARG B 215 GLY B 262 PHE B 318 SITE 3 AC1 10 PHE B 319 VAL B 321 SITE 1 AC2 14 HIS A 224 ALA A 227 PHE A 228 LEU A 235 SITE 2 AC2 14 MET A 250 VAL A 253 ARG A 263 THR A 266 SITE 3 AC2 14 LEU A 267 PHE A 270 GLY A 271 E4K A 401 SITE 4 AC2 14 ARG B 248 LEU B 324 SITE 1 AC3 10 ARG A 215 GLY A 262 PHE A 318 PHE A 319 SITE 2 AC3 10 VAL A 321 MET B 231 VAL B 249 HIS B 252 SITE 3 AC3 10 VAL B 253 E4K B 402 SITE 1 AC4 12 ARG A 248 GLU A 325 ALA B 227 PHE B 228 SITE 2 AC4 12 LEU B 235 VAL B 253 ARG B 263 THR B 266 SITE 3 AC4 12 LEU B 267 PHE B 270 GLY B 271 E4K B 401 CRYST1 46.710 46.710 47.493 74.74 74.74 61.83 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021409 -0.011465 -0.004022 0.00000 SCALE2 0.000000 0.024285 -0.004022 0.00000 SCALE3 0.000000 0.000000 0.022123 0.00000